NCT03976362 2026-02-25
KEYLYNK-008
Merck Sharp & Dohme LLC
Phase 3 Completed
Merck Sharp & Dohme LLC
Australasian Gastro-Intestinal Trials Group
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Celgene
Dana-Farber Cancer Institute